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Abstract	
	
INTRODUCTION:	Tuberculosis	(TB)	transmission	continues	to	be	problematic	in	the	United	States.	
Contact	investigations	are	essential	for	identifying	new	infections	and	must	prioritize	limited	resources	
by	pursuing	more	infectious	cases.	Current	infectivity	measures	like	sputum	smear	grade,	chest	x-rays,	
and	nucleic	acid	amplification	tests	(NAAT)	are	sub-optimal.	Time-to-detection	(TTD)	of	Mycobacterium	
tuberculosis	in	liquid	culture	has	shown	promising	results.	
OBJECTIVES:	Our	objective	is	to	examine	the	relationship	between	TTD	and	TB	transmission.	
METHODS:	This	study	examined	a	retrospective	cohort	of	pulmonary	TB	cases	with	TTD	data	from	2009-
2014	from	the	King	County	Laboratory,	Seattle,	WA.	The	primary	outcome	was	transmission	indicated	by	
previously	undiagnosed	latent	tuberculosis	infection	(LTBI)	in	household	contacts.	The	proportion	of	
contacts	positive	for	LTBI	was	modeled	using	Poisson	regression.	TTD,	highest	smear	grade,	NAAT,	and	
chest	x-ray	were	assessed	for	their	association	with	LTBI	in	contacts.	
RESULTS:	Of	390	pulmonary	TB	cases,	92	had	TTD	and	household	transmission	data.	Overall,	76.1%	of	
them	had	evidence	of	household	transmission.	Among	all	household	contacts,	36.5%	(187/512)	had	
previously	undiagnosed	LTBI,	including	33%	of	contacts	related	to	cases	with	long	TTD	and	30%	with	
negative	smears.		Short	(0-7	days)	TTD	was	significantly	associated	with	increased	LTBI	risk	compared	to	
long	TTD	(15+	days)	(RR:	1.39;	MH	X2	p-value:	0.025)	and	medium	TTD	(RR:	1.36;	MH	X2	p-value:	0.023).	
However	Poisson	modeling	of	transmission	rates	did	not	demonstrate	a	significant	relationship.	
Multivariate	analyses	adjusted	for	highest	smear,	NAAT,	and	chest	x-ray	were	also	non-significant.	All	
cases	with	short	TTD	were	smear	positive,	but	positive	smears	identified	60%	more	transmission	events.	
CONCLUSIONS:	In	this	limited	study,	short	TTD	was	not	a	promising	addition	to	current	infectivity	
measures.	Observational	studies	of	TB	transmission	are	difficult	when	there	are	high	background	rates	
of	LTBI.	Any	future	studies	should	take	place	in	previously	TB-naïve	households.	
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Introduction	
Worldwide,	9.6	million	people	are	estimated	to	have	fallen	ill	with	tuberculosis	(TB)	in	2014	for	a	
global	average	of	133	incident	cases	per	100,000	population1.	In	the	United	States,	9,421	cases	were	
identified	in	2014	with	an	incidence	rate	of	3.0	cases	per	100,000	population2.	In	low-incidence	settings,	
TB	control	programs	are	able	to	focus	on	TB	elimination,	as	well	as	controlling	TB	disease,	by	targeting	
latent	TB	infection	(LTBI).		
Contact	investigations	are	important	tools	for	infection	control	in	low-incidence	countries3.	
Investigations	begin	with	an	index	case	of	TB	disease	and	work	to	identify	any	contacts	who	may	have	
developed	LTBI	and	are	at	risk	for	progressing	to	TB	disease	or	those	who	already	have	developed	TB	
disease	(referred	to	as	secondary	cases).	The	probability	of	transmission	of	TB	depends	on	the	
infectiousness	of	the	case,	intensity	of	exposure,	and	susceptibility	of	contacts3.	These	factors	must	all	
be	taken	into	consideration;	yet	a	wide-cast	net	can	yield	a	very	small	number	of	newly	acquired	LTBI	or	
secondary	cases	per	contact	screened4.	US-based	investigations	that	focus	on	the	contacts	of	culture-
confirmed	pulmonary	cases	can	yield	fewer	than	1%	secondary	cases	and	21%	with	LTBI5.	Contact	
investigations	are	resource	and	time-consuming.	Public	health	entities	need	to	be	able	to	prioritize	
contact	investigations	that	are	more	likely	to	yield	newly	infected	contacts.	This	prioritization	hinges	on	
the	perceived	infectiousness	of	the	case6,7.		
TB	transmission	depends	on	the	patient’s	ability	to	aerosolize	bacilli	and	transmit	
Mycobacterium	tuberculosis	(MTB)6,7.	When	identified,	patients	suspected	of	having	TB	are	evaluated	
for	pulmonary	disease.	Clinicians	then	rely	on	four	diagnostic	tests	to	determine	infectiousness:	sputum	
smear	microscopy,	chest	radiography,	nucleic	acid	amplification	testing	(NAAT),	and	sputum	culture.		
Sputum	smear	microscopy	has	been	the	most	common	measure	of	infectivity.	High	smear	grade	
is	associated	with	a	high	burden	of	disease8,9.	TB	is	more	prevalent	among	contacts	of	heavily	smear-
positive	patients	(with	sputum	smears	in	the	3+	and	4+	range)	than	smear-negative	patients7,9,10.	Yet	
sputum	smear	sensitivity	ranges	from	22	to	80%	for	TB	disease11.	In	the	US,	contact	investigations	of	
smear-positive	patients	have	shown	1%	of	evaluated	contacts	developing	active	TB	and	27%	of	contacts	
contracting	LTBI5.	
Additionally,	a	smear-negative	result	does	not	indicate	a	lack	of	infectiousness.	Across	studies,	
approximately	50%	of	all	cases	of	pulmonary	TB,	regardless	of	HIV	status,	are	smear-negative12,13.	
Studies	have	estimated	that	smear-negative,	culture-positive	cases	account	for	13	to	18%	of	secondary	
cases	and	25	to	39%	of	LTBI	among	contacts14-16.	Thus	a	negative	sputum	smear	result	alone	does	not	
represent	an	insignificant	transmission	risk.		Sputum	smear	results	also	do	not	distinguish	MTB	from	
other	mycobacterial	species,	viable	from	unviable	organisms,	and	depend	on	the	patient,	the	type	and	
degree	of	pulmonary	involvement,	the	quality	of	the	sputum	sample	collected,	and	the	skill	of	the	
microscopist11,17,18.		
	 Chest	radiography	is	also	considered	when	determining	whether	and	how	to	conduct	contact	
investigations.	Cavitary	lesions	visible	on	x-rays	represent	the	largest	number	of	bacilli3,19.	A	greater	
presence	and	extent	of	cavitary	lesions,	density	of	lesions,	and	amount	of	lung	involved	correlate	with	
higher	burden	of	disease19.	However,	chest	x-ray	interpretations	have	been	shown	to	be	variable	across	
clinicians	and	TB	specialists20.	There	has	been	work	to	standardize	a	chest	x-ray	reading	and	recording	
system;	however,	it	has	not	been	implemented	widely21.	Additionally,	HIV	positive	individuals	are	less	
likely	to	have	cavitary	disease22	and	patients	with	diabetes	mellitus	tend	to	have	atypical	chest	x-ray	
presentations23.			
		 NAATs,	such	as	the	Xpert	MTB/RIF	test,	are	more	specific	than	microscopy	and	also	faster24.	A	
recent	meta-analysis	that	evaluated	125	studies	reported	pooled	sensitivity	and	specificity	to	be	85	and	
97%,	respectively25.	However,	both	measures	varied	significantly	across	studies,	so	much	so	that	the	
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authors	concluded	that	“summary	measures	of	diagnostic	accuracy	are	not	clinically	meaningful”25.	
NAAT	does	not	differentiate	between	viable,	dormant,	and	non-viable	intact	MTB	bacilli	shed	during	
effective	TB	treatment26.	Additionally,	NAAT	is	not	consistently	used	by	providers	despite	being	
recommended	by	the	CDC	because	of	concerns	of	cost-effectiveness	in	high-income,	low-incidence	
settings27,28.	
	 Culture	has	been	used	as	the	gold	standard	for	TB	disease	diagnosis.	It	is	the	most	sensitive	
method	for	TB	detection	and	requires	fewer	bacilli	to	produce	a	positive	result3.	Liquid	culture	methods,	
as	compared	to	solid	culture,	have	decreased	culture	time	to	as	few	as	2	days	while	still	preserving	
sensitivity29-31.	The	decreased	time-to-detection	(TTD)	for	MTB	in	culture	presents	an	opportunity	for	
public	health	officials	to	have	in-hand	culture	results	while	launching	contact	investigations.		
In	previous	studies,	TTD	has	been	evaluated	as	a	viable	alternative	to	colony	counting	and	thus	an	adept	
measure	of	bacillary	load32-34.	Pre-treatment	TTD	has	been	shown	to	be	associated	with	other	indicators	
of	bacterial	load	and	disease	severity,	including	sputum	smear	grading,	extensive	parenchymal	disease,	
and	number	of	cavities	on	a	chest	x-ray34-36.	Because	short	TTD	correlates	with	other	measures	of	
greater	bacillary	load,	TTD	has	the	potential	to	be	a	new	tool	to	measure	infectivity.	Already,	TTD	has	
been	studied	as	an	indicator	for	the	length	of	respiratory	isolation18.	It	has	also	been	studied	as	a	
predictor	for	transmission	to	contacts15.		
This	study	seeks	to	build	on	the	existing	literature,	which	argues	that	short	TTD	is	associated	
with	high	risk	of	TB	transmission.	Prior	literature	modeled	transmission	as	a	binary	contact	positivity	
variable	whereas	this	study	aims	to	look	at	the	rate	of	positive	contacts.	This	study	also	adjusts	for	
contacts	with	prior	positive	TB	screening	results,	something	previous	studies	have	not	done.		
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Methods	
Study	Population	
King	County	is	the	largest	county	in	Washington	with	a	population	of	approximately	2.1	million	
people.	In	King	County,	all	TB	cases	are	recorded	on	the	Report	of	a	Verified	Case	of	Tuberculosis	(RVCT)	
form,	which	is	then	stored	in	the	Public	Health	Information	Management	System	(PHIMS).	Between	
2009	and	2014,	672	cases	of	TB	were	counted	in	King	County.	For	this	study,	we	began	by	excluding	216	
extrapulmonary-only	TB	cases,	7	cases	diagnosed	post-mortem,	and	59	cases	that	were	not	culture	
confirmed	via	sputum	or	bronchiolar	lavage	specimens.	
For	the	remaining	390	active	pulmonary	TB	cases,	we	performed	detailed	medical	record	
review,	collecting	data	on	the	earliest	specimen	to	produce	a	positive	culture	result	(which	is	of	most	
interest	to	contact	investigations),	the	date	of	collection	of	the	specimen,	the	smear	grade	associated	
with	the	specimen,	the	highest	smear	grade	reported	for	any	specimen,	and	the	date	the	highest	smear	
grade	specimen	was	collected.	
Based	on	these	data,	we	observed	inconsistent	reporting	across	laboratories	of	the	date	a	
specimen	was	tested	versus	date	reported.	To	eliminate	interlab	variability	which	could	affect	
measurement	of	the	independent	variable,	only	King	County	Laboratory	reports	were	considered	and	
medical	record	data	was	extracted	for	the	first	culture-positive	specimen	at	the	King	County	Lab.	
Additional	exclusion	criteria	included	specimens	in	which	organisms	other	than	MTB	were	found,	
specimens	with	a	lab	error,	lab	records	that	could	not	be	located,	and	cases	that	did	not	have	a	King	
County	Lab	record.	Specimens	with	no	growth	and	therefore	no	time-to-detection	(TTD)	were	also	
excluded.	If	the	first	culture-positive	specimen	was	excluded,	the	case	was	also	excluded.	Finally,	
specimens	collected	after	anti-TB	treatment	was	begun	were	excluded	from	TTD	analysis	so	as	to	
prevent	the	effect	of	slower	growth	from	treatment.	The	final	cohort	of	individuals	with	culture	growth	
and	who	were	not	yet	receiving	anti-TB	treatment	totaled	124	individuals	[Figure	1].	
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Figure	1:	Study	Population	for	TTD	Analysis	
Measures	
The	primary	independent	variable	of	interest	was	time-to-detection	(TTD).	Using	King	County	
Lab	Report	data,	TTD	was	calculated	as	the	date	the	sample	was	tested	by	smear	microscopy—at	which	
time	aliquots	are	put	into	culture—to	the	date	the	preliminary	acid-fast	bacilli	(AFB)	culture	result	was	
tested.	If	there	was	no	report	of	a	preliminary	AFB	culture,	the	final	culture	testing	date	was	used.	
Consistent	with	the	previous	study,	we	treated	TTD	as	a	dichotomous	variable	(<9	days	or	>=9	
days	as	used	in	O’Shea	et	al.)15.	In	addition,	given	that	there	is	relatively	little	research	on	TTD	as	a	
predictor	of	infectivity,	we	explored	TTD	as	continuous	and	categorical.	The	categorical	cut	points	of	0-7	
days,	8-14	days,	and	15+	days	follow	week	intervals.	The	shorter	TTD	is,	the	more	useful	it	is	for	
informing	contact	investigation	strategies	when	they	begin.	Thus	the	first	two	weeks	were	distinguished	
from	any	other	time	frame.		
In	addition,	highest	smear	grade	reported	for	any	specimen	was	extracted	from	medical	record	
data.	Smear	grade	was	categorized	as	a	3-level	variable:	negative/indeterminate,	1+/2+,	and	3+/4+.		
Additional	clinical	variables	extracted	from	the	PHIMS	RVCT	records	included	diagnostic	results	
of	NAAT	and	radiographic	grade	of	chest	x-ray.	Radiographic	grade	of	chest	x-ray	was	conducted	by	two	
expert	TB	specialists	and	reported	via	the	RVCT	form.	The	chest	x-ray	variable	combined	3	surveillance	
variables	from	the	RVCT	form	and	categorized	the	results	as	(1)	normal	x-ray,	(2)	abnormal,	non-cavitary	
x-ray,	and	(3)	cavitary	x-ray.	One	case	in	the	sample	demonstrated	a	miliary	x-ray	and	was	classified	as	
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abnormal,	non-cavitary	for	this	study	after	a	second	expert	review	by	the	same	specialists.	Other	clinical	
variables	extracted	from	the	PHIMS	database	include	extrapulmonary	TB	disease,	previous	TB	diagnosis,	
HIV	status,	diabetes,	TNF-alpha	antagonist	therapy,	end-stage	renal	disease,	immunosuppression	(non	
HIV/AIDS),	and	post-organ	transplantation.		
Sociodemographic	covariates	were	also	extracted	from	the	PHIMS	database	and	included	age,	
sex,	place	of	birth,	and	race/ethnicity.	
The	dependent	variable	of	interest	was	LTBI	infection	in	contacts	of	a	case.	Contacts	of	cases	
were	identified	following	the	King	County	TB	Control	Program	protocol	using	the	concentric	circle	
approach.	Contact	data	were	recorded	in	a	county-controlled	MS	Access	database.	Exclusion	criteria	
included	contacts	with	no	record	of	a	tuberculin	skin	test	(TST)	or	QuanitFERON-TB	Gold	test	(QFT)	
result,	individuals	with	a	positive	TST	2	or	more	months	prior	to	the	case	starting	anti-TB	treatment,	and	
contacts	with	a	known	prior	positive	QFT.	The	remaining	susceptible	contacts	were	considered	positive	
for	LTBI	if	they	were	QFT-	or	TST-positive	(induration	>=5	mm).	
Primary	analysis	focused	on	household	contacts	of	cases	to	better	isolate	true	transmission	
events.	Secondary	analyses	expanded	the	contact	pool	to	include	household	contacts	and	all	contacts	
exposed	in	the	workplace,	school,	nursing	home,	shelter,	jail,	and	“other”	locations	[Figure	2].		
	
	
	
Figure	2.	Study	Population	for	Transmission	Analysis	
Laboratory	Methods	
Samples	were	assessed	via	smear	microscopy	using	two	methods:	the	direct	microscopy	
Carbolfuchsin	method	using	the	Ziehl-Neelsen	hot	acid-fast	stain,	and	the	fluorescent	microscopy	
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method	which	uses	auramine	stain	in	the	Morse,	Blair,	Weiser	and	Sproat	fluorescent	procedure.	
Samples	were	cultured	for	up	to	56	days	using	the	BACTEC	MGIT	960	Mycobacterial	Growth	Indicator	
Tube	system	(Becton	Dickinson;	Franklin	Lakes,	NJ).	Cultures	were	then	assessed	for	colony	
identification	using	Gen-Probe	AccuProbe	for	MTB.		TTD	was	defined	in	days	from	the	date	the	specimen	
was	plated	for	microscopy,	at	which	time	aliquots	were	created	and	inoculated	into	culture,	to	the	date	
the	specimen	demonstrated	sufficient	fluorescence	to	trigger	the	growth	detection	system.	King	County	
Laboratory	conducted	smear	microscopy	and	specimen	culture	and	identification.	The	Washington	State	
Lab	conducted	all	Nucleic	Acid	Amplification	Testing	(NAAT)	using	real-time	PCR	that	targets	insertion	
sequence	6110.	
Statistical	Analysis	
We	explored	TTD	as	continuous,	binary,	and	categorical	in	the	correlation	analyses	that	
compared	TTD	with	the	existing	infectivity	measures:	highest	smear	grade,	chest	x-ray,	and	NAAT.	We	
used	Spearman’s	rank	correlation	to	assess	the	correlation	between	TTD	(modeled	as	a	continuous	
variable)	and	existing	diagnostic	tests	(smear	grade,	chest	radiographic	grade,	and	NAAT).	When	
modeling	TTD	as	a	categorical	variable,	chi-square	tests	and	Fisher’s	exact	tests	were	used.	Sample	
characteristics	were	also	evaluated	using	chi-square	test	or	Fisher’s	exact	test	when	expected	cell	counts	
were	<5.		
We	decided	a	priori	that	in	the	transmission	model,	TTD	would	be	modeled	by	weeks	(0-7	days,	
8-14	days,	and	14+	days)	as	these	categories	had	the	greatest	practical	relevance	to	a	clinical	setting.	
Contact	investigations	usually	begin	following	a	positive	NAAT	or	culture	result,	with	some	exceptions.	
NAAT	is	much	more	expedient,	with	results	coming	back	in	days	rather	than	weeks.	Thus	contact	
investigations	can	begin	soon	after	the	initial	specimens	are	collected.	For	TTD	to	be	most	useful	in	
informing	a	contact	investigation	and	raising	suspicion	of	transmission,	clinicians	would	want	to	know	
whether	MTB	grew	within	the	first	two	weeks,	with	a	greater	importance	given	to	cultures	that	grow	in	
the	first	week.	
We	stratified	case	characteristics	by	TTD	and	assessed	for	statistical	differences	using	chi-square	
and	Fisher’s	exact	tests.	We	did	the	same	for	contact	characteristics.	We	also	modeled	the	relationship	
between	contact	characteristics	and	LTBI	status	using	logarithmic	regression.		
The	number	of	LTBI-positive	contacts	was	tabulated	as	count	data	for	each	case.	Total	contacts	
evaluated	per	case	were	also	tabulated.	The	transmission	event	rate—indicated	by	the	proportion	of	
contacts	positive	for	LTBI	per	case—was	modeled	using	Poisson	regression	with	the	Pearson’s	chi-square	
statistic	adjustment	for	overdispersion.	The	number	of	LTBI-positive	contacts	was	the	numerator;	
number	of	total	contacts	was	the	denominator;	and	the	natural	log	of	the	total	number	of	contacts	was	
the	offset	term.	
First,	we	did	univariate	analysis	using	Mantel-Haenszel	chi-square	tests	to	examine	the	
relationship	between	the	total	number	of	LTBI-positive	contacts	and	TTD,	smear	grade,	NAAT,	and	chest	
radiographic	grade.	Second,	Poisson	regression	was	used	to	analyze	the	univariate	association	between	
transmission	event	rate	and	TTD,	smear	grade,	NAAT,	and	chest	radiographic	grade.	Third,	we	analyzed	
multivariate	Poisson	models	that	included	TTD	in	combination	with	the	three	other	tests,	to	determine	
the	added	value	of	TTD.	A	final	model	included	all	of	the	tests.	We	also	introduced	case	characteristics—
specifically	sex,	HIV	status,	and	age—into	each	model	and	assessed	the	impact.	
All	statistical	analyses	were	conducted	using	the	SAS	9.3	software	package.	
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Results	
Sample	Characteristics	
	 A	total	of	124	out	of	390	(31.8%)	active	pulmonary	TB	cases	were	included	for	TTD	analysis.	
These	cases	had	MTB	culture	growth	in	the	King	County	Lab	prior	to	beginning	anti-TB	treatment.	Mean	
age	of	the	group	was	46.3	years	old;	62.9%	of	the	group	was	male	[Table	1A].	A	large	proportion	of	the	
sample	was	foreign-born	(86.3%),	with	the	predominant	ethnic	group	being	non-Hispanic	Asian	(62.1%).	
Age,	sex,	place	of	birth,	and	race/ethnicity	did	not	vary	significantly	by	TTD	in	weeks.	
	 Characteristics	of	TB	disease	such	as	highest	sputum	smear	grade	and	NAAT	did	vary	
significantly	by	TTD	in	weeks	(p-values:	<.001	and	0.011,	respectively)	[Table	1B].	Highest	sputum	smear	
grade	followed	a	bimodal	distribution	with	the	two	largest	categories	being	“Negative”	smear	grade	
(30.7%)	and	4+	smear	grade	(28.2%).	Overall,	63.7%	of	the	sample	was	NAAT-positive;	however,	a	
considerable	proportion	of	cases	did	not	have	a	NAAT	result	(21.8%).	Chest	radiographic	grade	did	not	
vary	significantly	by	TTD	in	weeks.		
	 Risk	factors	for	disease	were	also	examined.	The	most	prevalent	risk	factor	in	the	sample	was	
diabetes	(19.4%)	but	it	did	not	vary	significantly	by	TTD	in	weeks.	Nine	cases	had	extrapulmonary	TB	
disease	in	addition	to	their	pulmonary	TB;	9	had	been	previously	diagnosed	with	TB;	2	cases	were	HIV	
positive;	1	case	had	end-stage	renal	disease,	and	3	cases	had	immunosuppression	that	was	not	related	
to	HIV/AIDS.	None	of	these	risk	factors	were	associated	with	TTD	in	weeks.	No	individuals	in	the	sample	
had	TNF-alpha	antagonist	therapy	or	post-organ	transplantation.		
	 		
Table	1A.	Characteristics	of	Cases	with	Culture	Growth	and	No	Treatment	by	TTD	(N=124)	
Characteristic	
Totals	 Time-to-Detection	
P-Value	
N	 		 %	
0-7	
days	
8-14	
days	
15+	
days	
Age	 		
	
		 		
	
		 0.790	 *	
0-14	 2	
	
1.6	 0	 1	 1	 		 		
15-24	 18	
	
14.5	 1	 6	 11	 		 		
25-44	 46	
	
37.1	 7	 17	 22	 		 		
45-64	 30	
	
24.2	 4	 12	 14	 		 		
>=65	 28	
	
22.6	 5	 14	 9	 		 		
Sex	 		
	
		 		
	
		 		 		
Male	 78	
	
62.9	 11	 34	 33	 0.562	 		
Female	 46	
	
37.1	 6	 16	 24	 		 		
Place	of	birth	 		
	
		 		
	
		 0.106	 		
USA	 17	
	
13.7	 1	 11	 5	 		 		
Outside	USA	 107	
	
86.3	 16	 39	 52	 		 		
Race/Ethnicity	 		
	
		 		
	
		 0.420	 *	
Non-Hispanic	White	 12	
	
9.7	 1	 8	 3	 		 		
Hispanic	or	Latino	 8	
	
6.5	 2	 3	 3	 		 		
Non-Hispanic	Black	or	African	
American	 25	
	
20.2	 4	 8	 13	 		 		
Non-Hispanic	Asian,	Native	Hawaiian	
or	Other	Pacific	Islander	
79	 	 63.7	 10	 31	 38	
		 		
*Indicates	Fisher's	Exact	Test;	otherwise	Chi-Squared	test	was	used		
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Table	1B.	Characteristics	of	Diagnostic	Tests	by	TTD	(N=124)	
Characteristic	
Totals	 Time-to-Detection	
P-Value	
N	 		 %	
0-7	
days	
8-14	
days	
15+	
days	
Highest	Sputum	Smear	Grade	 		
	
		 		
	
		 <.001	 *	
Negative	 38	
	
30.7	 0	 10	 28	 		 		
Inconclusive	 10	
	
8.1	 0	 7	 3	 		 		
1+	 18	
	
14.5	 1	 8	 9	 		 		
2+	 12	
	
9.7	 1	 6	 5	 		 		
3+	 11	
	
8.9	 3	 6	 2	 		 		
4+	 35	
	
28.2	 12	 13	 10	 		 		
Chest	radiographic	grade	(N=117)	 		
	
		 		
	
		 0.842	 *	
Normal	 2	
	
1.7	 0	 1	 1	 		 		
Abnormal,	Not	cavitary**	 87	
	
74.3	 11	 33	 43	 		 		
Abnormal,	Cavitary	 28	
	
23.9	 5	 12	 11	 		 		
NAAT	(N=96)	 		
	
		 		
	
		 0.037	 *	
Negative	 17	
	
17.7	 0	 6	 11	 		 		
Positive	 79	 		 82.3	 12	 39	 28	 		 		
*Indicates	Fisher's	Exact	Test;	otherwise	Chi-Squared	test	was	used		
**Includes	miliary	case	(N=1)	
TTD	Distribution	
	 Among	124	cases	of	active	pulmonary	TB,	TTD	ranged	from	3	days	to	63	days.	Median	was	14	
days	and	mean	was	16.3	days	(standard	deviation:	9.6).	The	distribution	was	skewed	right	[Figure	3].	
	
	
Figure	3.	Distribution	of	TTD	in	Case	Cohort	with	Culture	Growth	and	No	Treatment	(N=124)	
For	this	study,	TTD	was	categorized	into	a	3-level	categorical	variable.	A	previous	study	followed	
a	dichotomization	approach15.	Distributions	within	each	category	are	noted	in	Table	2A	and	2B.	
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Table	2A	and	B.	Number	of	Cases	by	two	TTD	Categorization	Schemes	(Categorical	and	Dichotomous);	N=124	
	
	 	
	
	
	
For	transmission	analysis,	the	cohort	was	limited	to	92	cases	with	household	contacts.	In	this	
cohort,	TTD	ranged	from	3	to	43	days.	Median	was	13	days	and	mean	was	14.4	(days	standard	deviation:	
7.7).	The	distribution	was	still	skewed	right	yet	had	fewer	outliers	[Figure	4].	
	
	
Figure	4.	Distribution	of	TTD	in	Household	Transmission	Cohort	(N=92)	
	 TTD	categorization	by	week	followed	a	similar	but	more	normalized	distribution	as	with	the	TTD	
analysis	cohort	(N=124)	[Table	3A	and	3B].	
	
Table	3A	and	B.	Number	of	Cases	with	Household	Contacts	by	TTD	Categories;	N=92	
	
	 	
	
	
	
Correlation	Between	TTD	and	Smear	Grade/Chest	X-Ray/NAAT	
Among	cases	with	culture	growth	that	had	yet	to	undergo	anti-TB	treatment	(N=124),	TTD	
modeled	as	continuous	[Table	4A],	binary	[Table	4B],	and	categorical	[Table	4C]	all	correlated	
significantly	with	highest	sputum	smear	grade.	Chest	x-ray	(described	as	a	3-level	variable:	normal;	
abnormal,	not	cavitary;	and	abnormal,	cavitary)	did	not	correlate	with	any	of	the	TTD	categorizations.	
NAAT	demonstrated	a	significant	correlation	with	TTD	as	a	continuous	and	3-level	variable,	but	not	with	
the	dichotomous	variable.		
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Table	4A.	Correlation	between	TTD	(Continuous)	and	Diagnostic	Tests	
		 Correlation	coefficient	 P-Value	
Highest	Smear	grade	(N=124)	 -0.41796	 <.001	
Chest	X-ray	(N=117)	 -0.09674	 0.300	
NAAT	(N=96)	 -0.2216	 0.030	
*Spearman's	correlation	for	nonparametric	variables	
	
Table	4B.	Correlation	between	TTD	(Dichotomous)	and	Diagnostic	Tests	
		 Table	Value	 P-Value	
Highest	Smear	grade	(N=124)	 3.44E-07	 0.001*	
Chest	X-ray	(N=117)	 0.0607	 0.403*	
NAAT	(N=96)	 0.0412	 0.065*	
*Indicates	Fisher's	Exact	Test;	otherwise	Chi-Squared	test	was	used		
	
Table	4C.	Correlation	between	TTD	(Categorical)	and	Diagnostic	Tests	
		 Table	Value	 P-Value	
Highest	Smear	grade	(N=124)	 1.77E-13	 <.001*	
Chest	X-ray	(N=117)	 0.0098	 0.842*	
NAAT	(N=96)	 6.1221	 0.047	
*Indicates	Fisher's	Exact	Test;	otherwise	Chi-Squared	test	was	used		
	
	 Also	of	note,	the	smear	grade	of	the	TTD	specimen	significantly	correlated	with	highest	smear	
grade	but	the	correlation	was	not	perfect	(Spearman’s	correlation	coefficient:	0.668,	p-value:	<.001).	
There	were	instances	in	which	the	smear	grade	associated	with	the	TTD	specimen	was	negative	yet	the	
highest	smear	grade	archived	was	a	4+.	
Transmission	Analysis	
Transmission	was	analyzed	using	two	contact	groups:	household	contacts	only	and	all	contacts.	
Out	of	124	cases,	94	(75.8%)	had	790	total	susceptible	contacts	(either	household	or	non-household)	
that	completed	screening	[Table	5A].	Of	these,	92	(97.9%)	cases	had	household	contacts	(N=512);	16	of	
the	94	(17.0%)	cases	had	non-household	contacts	(N=278).	The	household	contact	cohort	is	considered	
the	most	accurate	representation	of	true	transmission	and	is	the	primary	focus	of	analysis.	All	contacts	
are	parsed	out	by	household	or	non-household	contacts	in	Table	5B.	
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Table	5A.	Total	Number	of	Contacts	by	TTD	Week	
	
All	Contacts	
	
Total	Cases	 Total	Contacts	 Contacts	per	case	
	
N	 %	 N	 %	 Mean	
Time-to-Detection	 		 		 		 		 		
0-7	days	 17	 18.1	 191	 24.2	 11.2	
8-14	days	 41	 43.6	 269	 34.1	 6.6	
15+	days	 36	 38.3	 330	 41.8	 9.2	
	
94	 		 790	
	
8.4	
ANOVA	F-Test	of	means	p-value:	0.3815	
	
Across	all	contacts,	short	TTD	was	associated	with	the	greatest	number	of	identified	contacts	
followed	by	long	TTD	and	then	medium	TTD	(11.2,	9.2,	and	6.6,	respectively),	however	this	relationship	
was	not	significant	[Table	5A].	
	
Table	5B.	Number	of	Contacts	by	TTD	Week—Stratified	by	Contact	Type	
	
Household	Contacts	Only	 Non-Household	Contacts	Only	
	
Cases	with	
Household	
Contacts	
Household	
Contacts	
Contacts	
per	case	
Cases	with		
Non-Household	
Contacts	
Non-Household	
Contacts	
Contacts	
per	case	
	
	
N	 %	 N	 %	 Mean	 N	 %	 N	 %	 Mean	
Time-to-Detection	 		 		 		 		 		 		 		 		 		 		
0-7	days	 17	 18.1	 131	 25.6	 7.7	 3	 18.8	 60	 21.6	 20.0	
8-14	days	 41	 43.6	 223	 43.6	 5.4	 5	 31.3	 46	 16.6	 9.2	
15+	days	 34	 38.3	 158	 30.9	 4.6	 8	 50.0	 172	 61.9	 21.5	
	
92	 		 512	
	
5.6	 16	
	
278	
	
17.4	
														ANOVA	F-Test	of	means	p-value:	0.0609	 								ANOVA	F-Test	of	means p-value:	0.6582	
	
Household	contacts	stratified	by	case	TTD	show	that	cases	with	short	TTD	had	the	highest	
average	number	of	identified	contacts	[Table	5B].	Across	all	cases,	the	mean	number	of	household	
contacts	identified	per	case	was	5.6	contacts/case.	Cases	with	short	(0-7	days),	medium	(8-14	days),	and	
long	TTD	(15+	days)	had	an	average	of	7.7,	5.4,	and	4.6	identified	household	contacts	per	case,	
respectively.	Non-household	contacts	do	not	show	this	same	relationship	and	instead	the	greatest	
number	of	identified	contacts	per	case	occurs	in	the	long	TTD	strata	(21.5	contacts/case),	followed	by	
short	TTD	and	medium	TTD	with	20.0	and	9.2	contacts/case,	respectively.		
In	contrast	to	the	original	cohort,	the	cohort	with	household	transmission	data	showed	a	
significant	association	between	place	of	birth	(US-born	vs	foreign-born)	and	TTD	(p-value:	0.027),	with	
median	TTD	being	disproportionately	represented	among	the	9	US-born	cases	[Table	6A].	Demographic	
characteristics	such	as	age,	sex,	and	race/ethnicity	were	also	not	significantly	associated	with	TTD.		
Similar	to	the	original	cohort	of	124	cases,	the	cohort	limited	to	those	with	household	
transmission	data	demonstrated	a	significant	association	between	TTD	in	weeks	and	highest	sputum	
smear	grade	(p-value:	0.003)	[Table	6B].	NAAT	was	no	longer	significantly	associated	with	TTD	(p-value:	
0.294).	Chest	radiographic	grade	continued	to	not	be	significantly	associated	with	TTD.		
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Table	6A.	Characteristics	of	Cases	with	Household	Transmission	Data	(N=92)	
Characteristic	
TOTALS	 Time-to-Detection	
P	Value	
N	 		 %	 0-7	
days	
8-14	
days	
15+	
days	
Age	 		
	
		 		
	
		 0.725	 *	
0-14	 1	
	
1.1	 0	 1	 0	 		 		
15-24	 9	
	
9.8	 1	 3	 5	 		 		
25-44	 40	
	
43.5	 7	 17	 16	 		 		
45-64	 22	
	
23.9	 4	 9	 9	 		 		
>=65	 20	
	
21.7	 5	 11	 4	 		 		
Sex	 	 	 	 	 	 	 	
Male	 59	
	
64.1	 11	 29	 19	 0.410	 		
Female	 33	
	
35.9	 6	 12	 15	 		 		
Place	of	birth	 		
	
		 		
	
		 0.015	 *	
USA	 9	
	
9.8	 1	 7	 1	 		 		
Outside	USA	 83	
	
90.2	 16	 34	 33	 		 		
Race/Ethnicity	 		
	
		 		
	
		 0.707	 *	
Non-Hispanic	White	 7	
	
7.6	 1	 5	 1	 		 		
Hispanic	or	Latino	 7	
	
7.6	 2	 3	 2	 		 		
Non-Hispanic	Black	or	African	American	 18	
	
19.6	 4	 6	 8	 		 		
Non-Hispanic	Asian,	Native	Hawaiian	or	
Other	Pacific	Islander	
60	 		 65.2	 10	 27	 23	
		 		
*Indicates	Fisher's	Exact	Test;	otherwise	Chi-Squared	test	was	used		
	
Table	6B.	Characteristics	of	Diagnostic	Tests	by	TTD	among	Cases	with	Household	Transmission	Data	(N=124)	
Characteristic	
TOTALS	 Time-to-Detection	
P	Value	
N	 		 %	 0-7	
days	
8-14	
days	
15+	
days	
Highest	Sputum	Smear	Grade	 		
	
		 		
	
		 0.003	 *	
Negative	 16	
	
17.4	 0	 4	 12	 		 		
Inconclusive	 8	
	
8.7	 0	 6	 2	 		 		
1+	 14	
	
15.2	 1	 7	 6	 		 		
2+	 12	
	
13.0	 1	 6	 5	 		 		
3+	 10	
	
10.9	 3	 6	 1	 		 		
4+	 32	
	
34.8	 12	 12	 8	 		 		
Chest	radiographic	grade	(N=87)	 		
	
		 		
	
		 0.984	 *	
Normal	 2	
	
2.3	 0	 1	 1	 		 		
Abnormal,	Not	cavitary**	 60	
	
69.0	 11	 25	 24	 		 		
Abnormal,	Cavitary	 25	
	
28.7	 5	 11	 9	 		 		
NAAT	(N=74)	 		
	
		 		
	
		 0.294	 *	
Negative	 11	
	
14.9	 0	 6	 5	 		 		
Positive	 63	
	
85.1	 12	 33	 18	 		 		
*Indicates	Fisher's	Exact	Test;	otherwise	Chi-Squared	test was	used		
**Includes	miliary	case	(N=1)	
	
Risk	factors	for	disease	present	in	the	cohort	included	extrapulmonary	TB	disease,	previous	TB	
diagnosis,	HIV,	diabetes,	and	non-HIV/AIDS	immunosuppression.	Diabetes	was	the	most	prevalent	risk	
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factor	(20.7%).	Extrapulmonary	TB	disease	(5	cases),	previous	TB	diagnosis	(6	cases),	HIV	(2	cases)	and	
immunosuppression	(2	cases)	were	uncommon.	No	risk	factor	was	significantly	associated	with	TTD.	
	 Household	contacts	were	significantly	more	likely	to	be	infected	if	they	were	older	(p-value:	
<.001)	[Table	7].	Contacts	who	were	25-44,	45-64,	and	65+	years	old	experienced	2.65,	3.35,	3.87	times	
the	odds	of	being	infected,	respectively,	as	compared	to	contacts	younger	than	15.	Household	contact	
infection	rates	also	varied	significantly	along	racial/ethnic	lines.	Non-Hispanic	blacks	experienced	2.76	
times	the	odds	of	being	infected	as	compared	to	Non-Hispanic	whites	(95%	CI:	1.19-6.38).	Non-Hispanic	
Asian,	Hawaiian,	or	other	Pacific	Islander	experienced	3.46	times	the	odds	(95%	CI:	1.74-6.89).	
Household	contacts	were	also	more	likely	to	be	foreign-born	(59.2%)	and	foreign-born	contacts	were	
8.61	times	as	likely	to	be	infected	as	US-born	contacts	(95%	CI:	5.66-13.09).	
	
Table	7.	Characteristics	of	Household	Contacts	(N=512)	
Contact	Characteristic	
Contacts	
TB	Infection	Status	 Likelihood	of	Infection	
Infected	 P-Value	 Odds	
Ratio	
95%	CI	
N	 %	 N	 Row	%	 Lower	 Upper	
Age	(N=760)	 		 		 		
	
<.001	 		
	
		
0-14	 137	 17.3	 29	 21.2	 		 Reference	
15-24	 200	 25.3	 32	 16.0	 		 0.71	 0.41	 1.24	
25-44	 200	 25.3	 77	 38.5	 		 2.33	 1.42	 3.84	
45-64	 138	 17.5	 54	 39.1	 		 2.39	 1.40	 4.08	
>=65	 85	 10.8	 29	 34.1	 		 1.93	 1.05	 3.54	
Sex	(N=784)	 		 		 		
	
0.145	
	 	
		
Male	 365	 46.6	 113	 31.0	 		 1.26	 0.92 1.72	
Female	 419	 53.4	 110	 26.3	 		 Reference	
Race	(N=704)	 		 		 		
	
<.001	
	 	
		
Non-Hispanic	White	 149	 21.2	 14	 9.4	 		 Reference	
Hispanic	or	Latino	White	 58	 8.2	 9	 15.5	 		 1.77	 0.72	 4.35	
Non-Hispanic	Black	or	African	
American	 79	 11.2	 27	 35.2	 	 5.01	 2.44	 10.29	
Non-Hispanic	Asian,	Hawaiian	or	
Other	Pacific	Islander	 396	 56.3	 158	 39.9	 	 6.40	 3.56	 11.50	
Other*	 22	 3.1	 6	 27.3	 		 3.62	 1.22	 10.73	
Place	of	birth	(N=790)	 		 		 		
	
<.001	
	 	
		
USA	 334	 42.3	 31	 9.28	 		 Reference	
Outside	USA	 393	 49.8	 184	 46.82	 		 8.61	 5.66	 13.09	
Unknown	 63	 8.0	 10	 15.87	 		 1.84	 0.85	 3.98	
Contact	Place	Exposed	(N=7T90)	 		 		 		
	
<.001	
	 	
		
Other	 57	 7.2	 3	 5.3	 		 0.10	 0.03 0.31	
Private	Residence	 512	 64.8	 187	 36.5	 		 Reference	
School	 150	 19.0	 14	 9.3	 		 0.18	 0.10	 0.32	
Shelter/Single	Residence	Occupancy	 8	 1.0	 1	 12.5	 		 0.25	 0.03	 2.03	
Work	 63	 8.0	 20	 31.8	 		 0.81	 0.46	 1.42	
Household	Contact	(N=790)	 		 		 		
	
		
	 	
		
Household	Contact	 512	 64.8	 187	 36.5	 		 3.63	 2.47 5.35	
Non-Household	Contact	 278	 35.2	 38	 13.7	 		 Reference	
HIV	Positive	(N=790)	 3	 0.4	 2	 66.7	 0.197	 5.06	 0.46	 56.06	
P-values	calculated	using	chi-square	or	Fisher’s	exact	test.	Odds	ratios	calculated	using	logistic	regression.	
*Other	race	includes	Native,	Other,	Mixed	Race,	and	Hispanic	Asian	
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Among	household	contacts,	the	aggregate	LTBI	prevalence	was	36.5%	(187/512).	Among	all	
contacts,	including	non-household	contacts,	the	aggregate	LTBI	prevalence	was	smaller	at	28.5%	
(225/790).		
Our	initial	examination	of	the	bivariate	relationships	between	proportion	of	LTBI	among	
contacts	and	the	diagnostic	test	were	examined	using	naïve	Mantel-Haenszel	chi-square	tests.	The	
proportion	of	LTBI-positive	household	contacts	for	short,	medium,	and	long	case	TTD	was	45.8%,	33.6%,	
and	32.9%,	respectively	[Table	8].	Contacts	of	cases	with	short	TTD	(0-7	days)	were	39.2%	more	likely	to	
be	infected	than	the	contacts	of	cases	with	long	TTD	(15+	days),	and	this	relationship	was	significant	(p-
value	0.025).	Contacts	of	cases	with	short	TTD	were	also	36.2%	more	likely	to	be	infected	than	those	of	
medium	TTD	cases	(p-value:	0.023).	
Short	TTD	appears	to	identify	the	greatest	proportion	of	LTBI-positive	contacts	(45.8%)	in	
comparison	to	a	highly	positive	3+/4+	smear	(40.8%)	or	any	positive	smear	(38.4%)	[Table	8].	However,	
short	TTD	only	identified	60	LTBI-positive	contacts	whereas	3+/4+	smear	identified	113	LTBI-positive	
contacts,	including	57/60	of	the	short	TTD	contacts.	Any	positive	smear	identified	155	LTBI-positive	
contacts	including	all	positive	short	TTD	contacts.	
	
Table	8.	LTBI	Among	Household	Contacts	by	Case	Characteristics	
Case	Characteristic	
LTBI-
Positive	
Contacts	
Total	
Contacts	
LTBI-Positive	
Contacts		
(Row	%)	
Rate	
Ratio	 P-Value	
All	Cases	 187	 512	 36.5	 		 		
Time-To-Detection	 		 		 		 		 		
0-7	days	 60	 131	 45.8	 1.392	 0.025	
8-14	days	 75	 223	 33.6	 1.022	 0.883	
15+	days	 52	 158	 32.9	 Reference	
Smear	 		 		 		 		 		
Negative/Inconclusive	 32	 108	 29.6	 Reference	
1+/2+	 42	 127	 33.1	 1.116	 0.572	
3+/4+	 113	 277	 40.8	 1.377	 0.043	
Smear	 		 		 		 		 		
Negative	 32	 108	 29.6	 Reference	
Positive	 155	 404	 38.4	 1.295	 	0.028	
Chest	radiographic	grade	(N=487)	 		 		 		 		 		
Normal	 1	 3	 33.3	 Reference	
Abnormal,	not	cavitary	 122	 339	 36.0	 1.080	 	0.924	
Abnormal,	cavitary	 63	 145	 43.4	 1.303	 	0.727	
NAAT	(N=411)	 		 		 		 		 		
Negative	 15	 64	 23.4	 Reference	
Positive	 129	 347	 37.2	 1.586	 	0.035	
P-values	calculated	using	Mantel-Haenszel	chi-square	tests	
	
When	we	reexamine	these	relationships	using	the	final	Poisson	statistical	model	for	the	analysis,	
this	time	examining	the	percentage	of	cases	that	had	at	least	one	household	contact,	TTD	was	not	
significant	(p-value:	0.087)	[Table	9;	Model	1.1,	Household	Transmission].	The	difference	in	
transmission	rates	between	medium	TTD	and	long	TTD	continued	to	be	non-significant.	Highest	smear	
grade,	chest	radiographic	grade,	and	NAAT	results	were	also	not	significantly	associated	with	household	
transmission	in	univariate	analyses	[Table	9;	Model	1.2-1.4,	Household	Transmission].	
In	contrast,	cases	with	short	TTD	and	medium	TTD	were	63.0%	and	50.3%,	respectively,	more	
likely	to	transmit	to	any	contact	(household	or	non-household)	compared	to	long	TTD	and	this	
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relationship	was	significant	(p-value:	0.023	and	0.043,	respectively)	[Table	9;	Model	1.1	All	
Transmission].		
Short	and	medium	TTD	continued	to	be	significantly	associated	with	increased	transmission	to	
all	contacts	in	bivariate	models	that	adjusted	for	highest	smear	grade	and	chest	radiographic	grade	
[Models	2.2,	2.3	All	Transmission]	and	that	adjusted	for	NAAT	and	chest	radiographic	grade	[Model	3.3,	
All	Transmission].	In	the	trivariate	model	that	adjusted	for	highest	smear	grade	and	chest	radiographic	
grade,	cases	with	medium	TTD	had	a	54.2%	higher	rate	of	transmission	to	any	contact	than	cases	with	
long	TTD,	and	this	relationship	was	significant	(p-value:	0.045)	[Model	3.1,	All	Transmission].		
In	the	full	model,	TTD	week,	adjusted	for	highest	smear	grade,	chest	radiographic	grade,	and	
NAAT	result,	was	not	significantly	associated	with	household	transmission	[Model	4.1,	Household	
Transmission	in	Table	9].	In	the	All	Transmission	model,	cases	with	medium	TTD,	adjusted	for	highest	
smear	grade,	chest	radiographic	grade,	and	NAAT,	were	71.0%	more	likely	to	transmit	to	any	contact	
than	cases	with	long	TTD	(p-value:	0.045)	[Model	4.1,	All	Transmission].	However,	a	likelihood	ratio	test	
of	all	variables	in	the	quadrivariate	model	demonstrated	that	no	infectivity	measure	was	a	statistically	
significant	predictor	of	all	transmission.	
Age,	sex,	and	HIV	status	covariates	were	also	included	in	the	models	detailed	in	Table	9,	
however	their	inclusion	did	not	affect	results	thus	they	were	not	presented.	
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Table	9.	Predictors	of	Transmission	from	Cases	
	
Household	
Transmission	(N=92)*	
All		
Transmission	(N=94)**	
Variable	 Rate	Ratio	 P-Value	
Rate	
Ratio	 P-Value	
MODEL	1.	UNIVARIATE	MODELS	 		 		
	
		
Model	1.1.Transmission	Rate	=	TTD	 		 		 		 		
Time	to	Detection	 		 		
	
		
0-7	days	 1.392	 0.087	 1.630	 0.023	
8-14	days	 1.022	 0.906	 1.503	 0.043	
15+	days	 Reference	 Reference	
Model	1.2.	Transmission	Rate	=	Smear	 		 		 		 		
Smear	Grade	 		 		
	
		
Negative/Inconclusive	 Reference	 Reference	
1+/2+	 1.116	 0.646	 0.655	 0.120	
3+/4+	 1.377	 0.118	 1.088	 0.714	
Model	1.3.Transmission	Rate	=	CXR	 		 		 		 		
Chest	X-Ray	 		 		
	
		
Normal	 Reference	 Reference	
Abnormal,	not	cavitary	 1.080	 0.937	 0.979	 0.987	
Abnormal,	cavitary	 1.303	 0.786	 0.745	 0.815	
Model	1.4.	Transmission	Rate	=	NAAT	 		 		 		 		
NAAT	 		 		
	
		
Negative	 Reference	 Reference	
Positive	 1.586	 0.103	 1.149	 0.699	
MODEL	2.	BIVARIATE	MODELS	 		 		 		 		
Model	2.1.	Transmission	Rate	=	TTD	+	Smear	 		 		 		 		
Time	to	Detection	 		 		
	
		
0-7	days	 1.242	 0.341	 1.440	 0.157	
8-14	days	 0.978	 0.907	 1.395	 0.117	
15+	days	 Reference	 Reference	
Smear	Grade	 		 		
	
		
Negative/Inconclusive	 Reference	 Reference	
1+/2+	 1.103	 0.691	 0.664	 0.128	
3+/4+	 1.242	 0.354	 0.924	 0.757	
Model	2.2.	Transmission	Rate	=	TTD	+	NAAT	 		 		 		 		
Time	to	Detection	 		 		
	
		
0-7	days	 1.359	 0.206	 1.781	 0.030	
8-14	days	 1.015	 0.945	 1.746	 0.022	
15+	days	 Reference	 Reference	
NAAT	 		 		
	
		
Negative	 Reference	 Reference	
Positive	 1.453	 0.205	 1.225	 0.576	
Model	2.3.	Transmission	Rate	=	TTD	+	CXR	 		 		 		 		
Time	to	Detection	 		 		
	
		
0-7	days	 1.344	 0.117	 1.590	 0.028	
8-14	days	 1.139	 0.464	 1.558	 0.029	
15+	days	 Reference	 Reference	
Chest	X-Ray	 		 		
	
		
Normal	 Reference	 Reference	
Abnormal,	not	cavitary	 0.993	 0.994	 0.845	 0.892	
Abnormal,	cavitary	 1.159	 0.881	 0.700	 0.774	
MODEL	3.	TRIVARIATE	MODELS	 	Household	Transmission*	 	All	Transmission**	
Model	3.1.	Transmission	Rate	=	TTD	+	Smear	+	CXR	 	RR	 	P-Value	 	RR	 	P-Value	
Time	to	Detection	 		 		
	
		
0-7	days	 1.323	 0.210	 1.538	 0.094	
8-14	days	 1.126	 0.526	 1.542	 0.045	
15+	days	 Reference	 Reference	
Smear	Grade	 		 		
	
		
Negative/Inconclusive	 Reference	 Reference	
1+/2+	 1.077	 0.756	 0.671	 0.146	
3+/4+	 1.058	 0.808	 0.830	 0.476	
Chest	X-Ray	 		 		
	
		
Normal	 Reference	 Reference	
Abnormal,	not	cavitary	 0.950	 0.959	 1.041	 0.981	
Abnormal,	cavitary	 1.106	 0.921	 0.905	 0.936	
Model	3.2.	Transmission	Rate	=	TTD	+	Smear	+	NAAT	 		 		 		 		
Time	to	Detection	 		 		
	
		
0-7	days	 1.386	 0.240	 1.495	 0.199	
8-14	days	 1.024	 0.917	 1.529	 0.103	
15+	days	 Reference	 Reference	
Smear	Grade	 		 		
	
		
Negative/Inconclusive	 Reference	 Reference	
1+/2+	 0.908	 0.741	 0.588	 0.136	
3+/4+	 0.912	 0.755	 0.831	 0.601	
NAAT	 		 		
	
		
Negative	 Reference	 Reference	
Positive	 1.496	 0.218	 1.235	 0.603	
Model	3.3.	Transmission	Rate	=	TTD	+	NAAT	+	CXR	 		 		 		 		
Time	to	Detection	 		 		
	
		
0-7	days	 1.357	 0.188	 1.759	 0.032	
8-14	days	 1.152	 0.503	 1.816	 0.020	
15+	days	 Reference	 Reference	
NAAT	 		 		
	
		
Negative	 Reference	 Reference	
Positive	 1.346	 0.315	 1.189	 0.645	
Chest	X-Ray	 		 		
	
		
Normal	 Reference	 Reference	
Abnormal,	not	cavitary	 0.749	 0.780	 0.630	 0.729	
Abnormal,	cavitary	 0.827	 0.856	 0.563	 0.669	
MODEL	4.	QUADRIVARIATE	MODELS	 		 		 		 		
Model	4.1.	Transmission	Rate	=	TTD	+	Smear	+	CXR	+	NAAT	 		 		 		 		
Time	to	Detection	 		 		
	
		
0-7	days	 1.543	 0.108	 1.667	 0.105	
8-14	days	 1.212	 0.381	 1.710	 0.045	
15+	days	 Reference	 Reference	
Smear	Grade	 		 		
	
		
Negative/Inconclusive	 Reference	 Reference	
1+/2+	 0.951	 0.859	 0.588	 0.128	
3+/4+	 0.779	 0.365	 0.702	 0.302	
Chest	X-Ray	 		 		
	
		
Normal	 Reference	 Reference	
Abnormal,	not	cavitary	 0.757	 0.792	 0.869	 0.915	
Abnormal,	cavitary	 0.829	 0.861	 0.798	 0.866	
NAAT	 		 		
	
		
Negative	 Reference	 Reference	
Positive	 1.538	 0.186	 1.242	 0.604	
*Cases	(N=92)	with	Transmission	Modeled	as	LTBI	among	Household	Contacts	Only	
**Cases	(N=94)	with	Transmission	Modeled	as	LTBI	among	All	Contacts	
Discussion	
Time	to	Detection	as	a	Predictor	of	Transmission	
The	primary	analyses	of	this	study	focused	on	risk	of	probable	transmission	to	household	
contacts	and	showed	that	in	this	group,	short	TTD	was	associated	with	a	greater	proportion	of	LTBI-
positive	results	compared	to	medium	and	long	TTD,	and	this	relationship	was	statistically	significant.	Yet	
the	proportion	of	LTBI	identified	by	short	TTD	was	only	5	percentage	points	greater	than	that	identified	
by	3+/4+	smears.	In	addition,	3+/4+	smears	identified	113	infections,	53	more	than	short	TTD,	including	
95%	of	the	cases	identified	by	short	TTD.		
Though	short	TTD	was	not	significantly	associated	with	transmission	in	univariate	or	multivariate	
analyses,	the	univariate	point	estimate	was	the	same	as	that	seen	in	the	LTBI	proportion	analysis	and	
thus	implicates	a	lack	of	power	to	detect	statistical	significance.	The	analyses	also	show	that	highest	
smear	grade—the	current	standard	metric	for	infectivity—also	performed	poorly	at	predicting	
household	transmission.	NAAT	and	chest	radiographic	grade	also	demonstrated	insignificant	
relationships,	however,	they	also	suffered	from	smaller	sample	sizes.	
Unexpectedly,	the	“All	Transmission”	cohort,	which	included	non-household	contacts,	did	
demonstrate	significant	predictors	of	transmission	in	several	models	including	the	TTD	univariate	model	
and	the	quadrivariate	model.	Across	all	contacts,	cases	with	short	and	medium	TTD	were	associated	
with	a	63.0%	and	50.3%	greater	transmission	rate	as	compared	to	cases	with	long	TTD,	not	adjusting	for	
other	diagnostic	tests.		
In	the	quadrivariate	model,	only	medium	TTD	remained	significantly	associated	with	
transmission.	In	comparison	to	long	TTD,	medium	TTD	was	associated	with	70.1%	greater	transmission	
rate	than	long	TTD,	after	adjusting	for	highest	smear,	chest	radiographic	grade,	and	NAAT,	and	
represented	a	higher	relative	rate	of	transmission	than	short	TTD.		
The	consistently	insignificant	results	in	the	household	transmission	models	are	likely	due	to	the	
high	background	rates	of	infection.	Among	household	contacts,	33%	were	associated	with	cases	with	
long	TTD	and	30%	were	linked	to	cases	with	negative	smears.	Household	contacts	were	more	likely	to	be	
foreign-born	(59.2%)	and	foreign-born	individuals	in	the	sample	were	more	likely	to	be	infected	than	US-
born	contacts.	In	the	literature,	foreign-born	contacts	are	more	likely	to	be	infected	prior	to	immigrating	
to	the	United	States37-39.	Because	there	is	no	way	to	distinguish	between	newly	or	previously	acquired	
LTBI,	infections	from	previous	exposures	cannot	be	excluded.	Thus,	a	high	background	rate	of	infection	
in	household	contacts	likely	contributes	to	the	high	proportion	of	LTBI	seen	in	the	contacts	of	cases	with	
long	TTD	(32.9%),	and	it	becomes	harder	to	find	a	statistically	significant	difference	in	infection	rates.		
Non-household	contacts,	by	contrast,	yielded	a	greater	proportion	of	US-born	individuals.	The	
proportion	of	foreign-born	contacts	in	the	“All	Contacts”	transmission	group	was	49.8%--almost	10	
percentage	points	less	than	household	contacts.	US-born	contacts	are	less	likely	to	have	LTBI	thus	the	
background	rate	of	LTBI	decreases	and	it	becomes	easier	statistically	to	find	a	difference	between	TTD	
strata.	However	the	non-household	contact	group	has	limitations	of	its	own	and	therefore	was	not	used	
for	primary	analyses.	Non-household	contacts	are	less	likely	to	have	as	high	an	exposure	to	the	case	as	
household	contacts	and	therefore	are	less	likely	to	be	a	true	transmission	event	from	the	index	case.	
Across	all	contacts,	household	contacts	had	greater	odds	of	infection	than	non-household	contacts.	
However	this	is	not	necessarily	always	the	case.	Some	individuals	may	spend	more	time	outside	the	
home	and,	for	example,	at	the	workplace	with	coworkers.	This	level	of	detail	is	not	contained	in	the	
contact	data.	
Additionally,	the	sample	of	non-household	contacts	is	heavily	affected	by	large	contact	
investigations.	Among	non-household	contacts,	the	largest	group	of	contacts	associated	with	a	single	
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case	was	a	school-based	investigation	in	which	95	contacts	were	screened,	which	produced	8	(8.4%)	
LTBI-positive	contacts.	These	large-scale	investigations	skew	results.	Though	cases	with	short	TTD	
tended	to	have	more	contacts	per	case	including	household	contacts	per	case,	on	average	there	were	
more	non-household	contacts	per	case	for	the	long	TTD	group.		
Because	we	predicted	there	to	be	lower	levels	of	exposure	among	non-household	contacts,	we	
expected	the	household	contact	transmission	models	to	produce	more	significant	results.	Overall,	the	
transmission	rate	among	household	contacts	was	greater	than	the	rate	across	all	contacts.	However	it	
appears	that	the	background	rate	of	infection	greatly	impacted	the	power	needed	to	find	statistical	
significance.	
Representativeness	of	the	Sample	
The	case	sample	appeared	to	be	demographically	representative	of	TB	nationally.	Overall,	62.9%	
of	the	group	was	male,	in	keeping	with	nationwide	findings	that	men	are	around	1.5	to	2	times	more	
likely	to	have	TB	than	women2.	A	large	proportion	of	the	sample	was	foreign-born	(86.3%),	with	the	
predominant	ethnic	group	being	non-Hispanic	Asian	(62.1%).	Nationwide	averages	show	that	66%	of	
reported	TB	cases	occurred	among	foreign-born	persons	and	that	Asian,	Native	Hawaiian	and	Pacific	
Islander	ethnic	groups	disproportionately	have	the	greatest	rates	of	TB2.	Seattle	is	an	international	hub	
for	immigration,	specifically	from	East	African	and	East	Asian	countries.	Thus	there	is	a	greater	
proportion	of	foreign-born	cases	in	the	county	than	across	the	United	States40.	
	The	household	transmission	case	cohort	(N=92)	differed	significantly	from	298	excluded	
pulmonary	TB	cases	by	highest	smear	grade,	culture	status,	NAAT,	anti-TB	treatment	prior	to	specimen	
collection,	extrapulmonary	TB	disease,	and	HIV	status.	Culture	status	and	anti-TB	treatment	were	part	of	
the	inclusion/exclusion	criteria	and	thus	the	difference	was	by	design.	The	household	transmission	case	
cohort	was	more	likely	to	have	higher	smear	grades	and	positive	NAAT	than	the	excluded	cases,	and	was	
less	likely	to	have	extrapulmonary	TB	disease	and	HIV.	
Limitations	
There	were	profound	limitations	unique	to	this	study	as	well	as	limitations	that	are	common	to	
the	field	of	observational	TB	research.	Specific	to	this	study,	there	are	challenges	to	the	underlying	data	
validity.	The	specimen	analyzed	for	TTD	is	the	first	culture-positive	specimen	analyzed	at	the	King	
County	Public	Health	Lab.	It	is	not	necessarily	the	diagnostic	specimen.	In	fact,	most	cases	are	diagnosed	
in	the	community	and	then	referred	to	the	county	TB	Control	Program.	The	main	consequence	of	this	
time	lag	between	diagnosis	and	analysis	is	that	many	of	the	cases	began	their	TB	treatment,	which	has	
been	shown	to	impact	culture	growth35,36.	We	buffered	against	this	impact	by	excluding	cases	that	had	
begun	treatment	prior	to	the	date	of	collection	of	the	TTD	specimen	(N=139;	35.6%)	resulting	in	124	
cases.	It	was	important	for	the	study	to	specifically	use	the	King	County	Lab	results	because	it	has	
consistent	record-keeping	of	dates	tested	versus	dates	reported	which	allowed	for	a	systematic	and	
accurate	calculation	of	TTD.	Inter-laboratory	variability	could	lead	to	measurement	error	in	the	predictor	
variable.	There	were	33	cases	with	no	King	County	Lab	(8.5%).	By	employing	strict	measures	to	improve	
data	quality,	sample	size	was	reduced,	and	consequently	statistical	power.	
Measurement	of	TTD	posed	other	challenges,	as	well.	Culture	samples	are	supposed	to	only	be	
cultured	for	56	days,	after	which	they	are	determined	culture-negative.	Yet	one	case	in	the	TTD	analysis	
cohort	(N=124)	had	a	TTD	of	63	days.	Additionally,	the	fluorescence	that	indicates	growth	has	to	be	
recorded	by	a	lab	technician.	If	the	culture	specimen	reaches	critical	mass	for	the	MGIT	system	to	detect	
fluorescence	during	the	weekend,	the	date	tested	would	only	be	recorded	the	following	workday.	
Therefore	holidays	and	weekends	could	have	caused	non-differential	misclassification	of	TTD.	
Another	limitation	to	using	the	first	culture-positive	specimen	from	the	King	County	Lab	is	that	it	
is	not	necessarily	the	specimen	with	the	shortest	TTD.	There	could	have	been	other	samples	with	a	
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different	culture	growth	time.	However	the	first	culture-positive	specimen	is	what	is	practically	useful	to	
contact	investigations	thus	that	is	the	sample	we	used.		
NAAT	data	came	from	the	PHIMS	database	RVCT	records—the	standard	report	required	for	
every	diagnosed	TB	case—and	had	substantial	missingness.	Of	cases	included	for	TTD	analysis	and	
household	transmission	analysis,	22.6%	and	19.6%	did	not	have	NAAT	results,	respectively.		
	 Chest	radiographic	grade	categorization	may	have	driven	non-significant	associations.	In	this	
study,	the	variable	was	classified	into	three	categories	(normal;	abnormal,	non-cavitary;	and	abnormal,	
cavitary).	Other	studies	have	included	categorizations	that	distinguish	between	unilateral	and	bilateral	
cavitary	disease,	a	single	cavitation	and	multiple,	as	well	as	predominantly	alveolar	and	predominantly	
interstitial	infection15,22.	It	has	been	shown	that	multiple	cavitations	are	associated	with	a	shorter	TTD	
and	greater	burden	of	disease41.	Thus	a	3-tier	categorization	may	have	been	too	coarse.	However	a	
greater	number	of	categories	would	have	also	reduced	sample	sizes	and	thus	power.	
	 Transmission	analysis	introduces	an	additional	set	of	limitations.	The	primary	challenge	to	
determining	whether	transmission	occurred	is	discerning	whether	a	contact’s	LTBI	truly	came	from	the	
case	in	this	study.	There	is	no	way	to	genotype	LTBI	thus	transmission	from	a	given	source	case	cannot	
be	genotypically	confirmed.	Additionally,	LTBI	is	common	worldwide.	The	WHO	estimates	that	more	
than	2	billion	people	--or	a	quarter	of	the	global	population--have	LTBI42.	Foreign-born	contacts	come	
from	a	variety	of	high-TB	prevalence	countries	thus	it	is	likely	that	exposure	occurred	before	
immigrating.		
	 Foreign-born	contacts	are	also	more	likely	to	have	received	the	BCG	vaccine,	which	can	lead	to	
an	unreliable	TST	result.	BCG	vaccine	has	been	shown	to	variably	interfere	with	TST	reactivity43.	Thus	it	
becomes	additionally	challenging	to	determine	whether	or	not	the	TST	results	are	a	product	of	LTBI	or	
the	vaccine.	Older	contacts	are	also	more	likely	to	be	LTBI-positive	from	a	previous	exposure2.	In	this	
study,	contact	age	was	significantly	associated	with	LTBI.	It	is	also	difficult	to	account	for	contact	
susceptibility.	HIV	infection	data	among	contacts	is	unreliable	as	well	as	documentation	of	other	risk	
factors.	
	 Finally,	it	is	challenging	to	appropriately	account	for	opportunities	for	transmission.	In	general,	
household	contacts	are	thought	to	have	greater	exposure	to	the	case,	than	non-household	contacts.	
However	it	is	not	always	the	case.	Overall,	it	is	difficult	to	account	for	the	length	of	exposure,	and	this	
level	of	detail	is	not	contained	in	the	contact	data.	
	 These	contact	characteristics,	which	speak	to	contact	susceptibility,	likely	confounded	the	
results	and	due	to	the	modeling	technique	could	not	be	appropriately	adjusted	for.	
Future	Studies	
Those	conducting	future	analyses	may	want	to	refine	the	contact	group	and	remove	foreign-
born	contact	TST	results.	Considering	a	large	proportion	of	foreign-born	individuals	are	BCG-vaccinated,	
QFT	is	be	a	more	reliable	measure	of	infection.	Another	possibility	is	to	limit	the	contact	cohort	to	
individuals	who	have	a	record	of	a	negative	TST	and	then	convert	to	a	positive	result.	These	would	
represent	the	most	accurate	true	transmission	events	and	thus	could	provide	the	most	accurate	
measure	of	transmission.		
Additionally,	studies	may	want	to	consider	modeling	techniques	other	than	Poisson	regression.	
Though	Poisson	was	able	to	take	into	account	the	number	of	LTBI-positive	contacts	within	the	context	of	
the	total	number	of	contacts,	it	could	not	adjust	for	contact	susceptibility.	
Finally,	future	surveillance	efforts	must	make	a	better	effort	to	collect	complete	data	on	
contacts	in	contact	investigations.	Only	through	thorough	cleaning	was	the	dataset	usable.		
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Conclusions	
While	TTD	appears	to	have	some	ability	to	discriminate	between	more	and	less	infectious	TB	
cases,	we	were	unable	to	show	it	added	to	current	infectivity	measures,	especially	to	the	use	of	3+/4+	
smear	grade	positivity.	Sample	size	also	contributed	greatly	to	the	lack	of	statistical	power.	There	are	
substantial	challenges	to	conducting	observational	studies	of	TB	transmission,	particularly	where	there	
are	high	background	rates	of	LTBI.	As	one	clinician	said,	“Smear	[the	current	gold	standard	of	infectivity]	
being	non-significant	validates	the	difficulty	of	telling	what	actually	happens	with	transmission	in	
contact	investigations.”	Future	studies	to	determine	the	usefulness	of	diagnostic	tests	to	predict	
transmission	should	take	place	in	previously	TB-naïve	households.	
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